Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Stage D2 metastatic carcinoma of the prostate
Age: Adult
Dose: Oral tablet – 50 mg
Frequency: once daily (morning or evening)
Note: Indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Not applicable – No approved pediatric dosage available
Note: There is no approved pediatric dosage available for this medication.

Renal Dose

Clinical InformationAdministration Information
Condition: Renal Impairment
Dose: Tablet – 50 mg
Note: Renal impairment (as measured by creatinine clearance) had no significant effect on the elimination of total bicalutamide or the active R-enantiomer. No dosage adjustment is necessary.
Administration
  • Can be taken with or without food
  • Take at the same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Coumarin Anticoagulants (Warfarin, Heparin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban)
Enhances effect

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at controlled room temperature, 20° to 25° C.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.